All these findings support our data, regarding the involvement of miR-223 and its target STAT5A in both anti-migratory and pro-chemotherapeutic effects and guide us to configure miR-223 as a player of the microenvironment in breast cancer. This evidence concerns the gene STAT5A and breast carcinoma.